Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the rat

Synapse

Volumn 24, Issue 3, 1996, Pages 256-261

  Stoessl, A Jon ^a,b   Rajakumar, Nagalingham ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Neuroleptic; Rat; Subthalamic nucleus; Tardive dyskinesia; Vacuous chewing movements

Indexed keywords

FLUPHENAZINE DECANOATE; NEUROLEPTIC AGENT; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN INJURY; CONTROLLED STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MASTICATION; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RAT; SNIFFING; SUBTHALAMIC NUCLEUS; TARDIVE DYSKINESIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; DYSKINESIA, DRUG-INDUCED; FLUPHENAZINE; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; THALAMIC NUCLEI;

EID: 0029987352     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199611)24:3<256::AID-SYN8>3.0.CO;2-D     Document Type: Article

References (45)

1. Albin, R.L., Young, A.B., and Penney, J.B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci., 12:366-375.
2. Alexander, G.E., and Crutcher, M.D. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci., 13:266-271.
3. Andersson, U., Eckernas, S.-A., Hartvig, P., Ulin, J., Langstrom, B., and Haggstrom, J.-E. (1990) Striatal binding of C-11-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding. J. Neural Transm., 79:215-226.
4. Bergman, H., Wichmann, T., and DeLong, M.R. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science, 249:1436-1438.
5. Blanchet, P.J., Boucher, R., and Bedard, P.J. (1994) Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys. Brain Res., 650:32-39.
6. Burt, D.R., Creese, I., and Snyder, S.H. (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science, 196:326-328.
7. Chergui, K., Akaoka, H., Charlety, P.J., and et al. (1994) Subthalamic nucleus modulates burst firing of nigral dopamine neurones via NMDA receptors. NeuroReport, 5:1185-1188.
8. Clow, A., Jenner, P., and Marsden, C.D. (1979) Changes in dopamine-mediated behaviour during one year's neuroleptic administration. Eur. J. Pharmacol., 57:365-375.
9. Delfs, J.M., Ellison, G.D., Mercugliano, M., and Chesselet, M.F. (1995) Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia. Exp. Neurol., 133:175-178.
10. Diana, M., Collu, M., Mura, A., and Cessa, G.L. (1992) Haloperidol-induced vacuous chewing in rats: suppression by α-methyl-tyrosine. Eur. J. Pharmacol., 211:415-419.
11. Dogali, M., Fazzini, E., Kolodny, E., Eidelberg, D., Sterio, D., Devinsky, O., and Berk, A. (1995) Stereotactic ventral pallidotomy for Parkinson's disease. Neurology, 45:753-761.
12. Egan, M.F., Hurd, Y, Hyde, T.M., Weinberger, D.R., Wyatt, R.J., and Kleinman, J.E. (1994) Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse, 18:178-189.
13. Ellison, G. (1991) Spontaneous orofacial movements in rodents induced by long-term neuroleptic administration: a second opinion. Psychopharmacology, 104:404-408.
14. Feger, J., Mouroux, M., and Hassani, O.-K. (1995) Increased subthalamic neuronal activity in dopaminergic rats not related to a decreased pallidal inhibition. Soc. Neurosci. Abstr., 21:913.
15. Fibiger, H.C., and Lloyd, K.G. (1984) Neurobiological substrates of tardive dyskinesia: the GABA hypothesis. Trends Neurosci., 7:462-464.
16. Gunne, L.-M., Haggstrom, J.-E., and Sjoquist, B. (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature, 309:347-349.
17. Gunne, L.M., Andersson, U., Bondesson, U., and Johansson, P. (1986) Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol. Biochem. Behav., 25:897-901.
18. Jicha, G.A., and Salamone, J.D. (1991) Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. J. Neurosci., 11:3822-3829.
19. Johnson, A.E., Coirini, H., Kallstrom, L., and Wiesel, F.-A. (1995) Characterization of dopamine receptor binding sites in the subthalamic nucleus. NeuroReport, 5:1836-1838.
20. Kane, J.M., and Smith, J.M. (1982) Tardive dyskinesia: prevalence and risk factors, 1959-1979. Arch. Gen. Psychiatry, 39:473-481.
21. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J. Neural Transm., 75:1-10.
22. Kreiss, D.S., Anderson, L.A., and Walters, J.R. (1995) Subthalamic nucleus neuronal activity is increased by dopamine D1 receptor agonists. Soc. Neurosci. Abstr., 21:914.
23. Laitinen, L.V., Bergenheim, A.T., and Hariz, M.I. (1992) Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J. Neurosurg., 76:53-61.
24. Lee, M.S., and Marsden, C.D. (1994) Movement disorders following lesions of the thalamus or subthalamic region. Mov. Disord. 9: 493-507.
25. Lieberman, J., Pollack, S., Lesser, M., and Kane, J. (1988) Pharmacologic characterization of tardive dyskinesia. J. Clin. Psychopharmacol., 8:254-260.
26. Limousin, P., Pollak, P., Benazzouz, A., Hoffmann, D., Le Bas, J.-F., Broussolle, E., Perret, J.E., and Benabid, A.-L. (1995) Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet, 345:91-95.
27. Mansour, A., Meador-Woodruff, J.H., Zhou, Q., Civelli, O., Akie, H., and Watson, S.J. (1992) A comparison of D1 receptor binding and mRNA in rat brain. Neuroscience, 46:959-971.
28. Mitchell, I.J., Crossman, A.R., Liminga, U., Andren, P., and Gunne, L.M. (1992) Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey. Mov. Disord. 7:32-37.
29. Parent, A., and Hazrati, L.-N. (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev., 20:128-154.
30. Parry, T.J., Eberle-Wang, K., Lucki, I., and Chesselet, M.F. (1994) Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Exp. Neurol., 128:181-190.
31. Paxinos, G., and Watson, C. (1986) The rat brain in stereotaxic coordinates (2nd Ed.). Academic Press, Sydney.
32. Rosales, M.G., Flores, G., Hernandez, S., Martinez-Fong, D., and Aceves, J. (1994) Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain Res., 645:335-337.
33. Rupniak, N.M.J., Jenner, P., and Marsden, C.D. (1983) Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats. Psychopharmacology, 79:226-230.
34. Rupniak, N.M.J., Jenner, P., and Marsden, C.D. (1985) Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology, 85:71-79.
35. Ryan, L.J., and Sanders, D.J. (1993) Subthalamic nucleus lesion regularizes firing patterns in globus pallidus and substantia nigra pars reticulata neurons in rats. Brain Res., 626:327-331.
36. Smith, I.D., and Grace, A.A. (1992) Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse, 12:287-303.
37. Spooren, W.P.J.M., Helfrich, S.E.M., and Cools, A.R. (1995) Interactions of the subthalamic nucleus and the subpallidal area in orofacial dyskinesia: role of GABA and glutamate. Psychopharmacology, 119:20-26.
38. Stoessl, A.J., Dourish, C.T., and Iversen, S.D. (1989) Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective D1 and D2 receptor antagonists. Psychopharmacology, 98:372-379.
39. Sutton, J.P., Couldwell, W., Lew, M.F., Mallory, L., Grafton, S., DeGiorgio, C., Welsh, M., Apuzzo, M.L.J., Ahmadi, J., and Waters, C.H. (1995) Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery, 36:1112-1117.
40. Tarsy, D., and Baldessarini, R.J. (1973) Pharmacologically induced behavioural supersensitivity to apomorphine. Nature New Biol., 245:262-263.
41. Trugman, J.M., Leadbetter, R., Zalis, M.E., Burgdorf, R.O., and Wooten, G.F. (1994) Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Mov. Disord. 9:441-446.
42. Waddington, J.L. (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology, 101:431-447.
43. Waddington, J.L., and Gamble, S.J. (1981) Prolonged dopamine receptor blockade in rats after termination of long-term depot fluphenazine. Lancet, 1:1375-1376.
44. Wichmann, T., Bergman, H., and DeLong, M.R. (1994) The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J. Neurophysiol., 72: 521-530.
45. Wirshing, W.C., Freidenberg, D.L., Cummings, J.L., and Bartzokis, G. (1989) Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism. J. Clin. Psychopharmacol., 9:407-411.